Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 2/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 4/20 | 0.31 |
| ▸ | PDE5A | O76074 | 1/20 | 0.31 |
| ▸ | PDE1A | P54750 | 1/20 | 0.31 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.31 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4508872 | 0.87 | PLA2G2A (0.39) | XDHPLA2G2A | |
| SCHEMBL4514644 | 0.85 | KCNH2 (0.38) | XDH | |
| SCHEMBL4504635 | 0.84 | — | — | |
| SCHEMBL4519262 | 0.82 | OPRK1 (0.33) | — | |
| SCHEMBL4515040 | 0.80 | CYP2D6 (0.34) | — | |
| SCHEMBL13711483 | 0.78 | PARP1 (0.36) | XDHPDE5APDE1APDE1BPDE4D | |
| SCHEMBL4505572 | 0.76 | SMN1; SMN2 (0.35) | — | |
| SCHEMBL4517190 | 0.76 | PARP1 (0.38) | XDHPDE5APDE1APDE1BPDE4D | |
| SCHEMBL5114154 | 0.74 | PLA2G2A (0.39) | XDHPLA2G2A | |
| SCHEMBL5197378 | 0.74 | OPRM1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7589104-B2 | Tricyclic-bridged piperidinyline derivatives as §-opioid modulators | JANSSEN PHARMACEUTICA NV (BE) | 2009-09-15 | — | — | US | disclosed |
| US-7589104-B2 | Tricyclic-bridged piperidinyline derivatives as §-opioid modulators | JANSSEN PHARMACEUTICA NV (BE) | 2009-09-15 | — | — | US | disclosed |